6.2.15
Genome editing tools jaise CRISPR-Cas9 humein life ki instruction manual ko rewrite karne dete hain — sasta, jaldi, aur precisely. Core ethical tension simple hai: sirf isliye ki hum DNA badal SAKTE hain, kya humein CHAHIYE? Yeh stakes aur bhi zyada ho jaati hain jab edit future generations ko pass hoti hai jinhone kabhi consent nahi diya.
Definition Genome editingKisi organism ki DNA sequence ka jaanbujhkar badlav — bases ko insert, delete, ya replace karna — molecular tools ki madad se (sabse famous CRISPR-Cas9 ). Ethics isliye aati hai kyunki DNA edits identity, future generations, aur society ko aisi tarah affect kar sakti hain jo mushkil ya impossible hai reverse karna.
Sabse important ethical dividing line:
Almost har exam answer chaar pillars se build kiya ja sakta hai. Inhe seekho aur tum kisi bhi scenario ka answer generate kar sakte ho.
Definition Chaar ethical pillars
Autonomy / Consent — kya affected person ne agree kiya? (Germline = future people consent nahi de sakte .)Beneficence vs Non-maleficence — acha karo vs "koi nuksaan na karo"; cure ko off-target risks ke saath weigh karo.Justice / Equity — access kise milta hai? Risk of "genetic divide" ameer aur garib ke beech.Human dignity / "playing God" — kya humein genome ko sacred / design-na-karne-wala treat karna chahiye?
WHAT: Therapy = koi bimari theek karna (e.g. sickle-cell mutation correct karna). Enhancement = "improvements" add karna (height, muscle, intelligence).WHY yeh contested hai: Line blurry hai. Kya immunity boost karna therapy hai ya enhancement? Enhancement se designer babies aur eugenics ka risk hai.HOW judge kiya jaata hai: Zyaatar bioethicists serious disease ke liye therapy accept karte hain lekin non-medical enhancement ka virodh karte hain.
WHAT: CRISPR unintended sites par cut kar sakta hai (off-target effects) ya mosaicism cause kar sakta hai (kuch cells edited, kuch nahi).WHY serious hai: Germline editing mein ek error heritable aur irreversible hota hai.HOW address kiya jaata hai: Higher-fidelity Cas variants, deep sequencing verification, long-term follow-up.
Germline edits un logon ko bind karti hain jo abhi exist nahi karte — ultimate consent problem.
Expensive tech sirf wealthy tak pahunch sakti hai → ek heritable biological class divide .
"Desirable" traits choose karna historical eugenics ki yaad dilaata hai; disability ke liye intolerance badh sakti hai.
Kya hamare paas human gene pool redesign karne ki wisdom hai? Genetic diversity ka loss ek real biological risk hai.
Worked example Case: He Jiankui (2018) — CCR5 "CRISPR babies"Kya hua: Ek scientist ne human embryos (twins) mein CCR5 gene edit kiya, yeh claim karte hue ki unhe HIV-resistant banaya ja raha hai, aur woh born hue.
Yeh step kyun (analysis):
Autonomy — babies ek heritable change ke liye consent nahi de sakte the. ✗Non-maleficence — CCR5 loss doosre viruses se risk badhata hai; off-target unknown. ✗Therapy vs enhancement — HIV doosre means se preventable hai → yeh justified therapy nahi tha. ✗Justice/oversight — secretly kiya gaya, koi ethics approval nahi. ✗
Outcome: Global condemnation; usse jail hua. Galat tarike ka textbook example ban gaya.
Worked example Case: Somatic CRISPR for Sickle-Cell (Casgevy, approved 2023)Kya hai: Ek patient ke khud ke blood stem cells bahar body ke edit kiye jaate hain taaki fetal haemoglobin reactivate ho, phir return kiye jaate hain.
Kyun widely accepted hai:
Edit somatic hai → nahi inherit hoti → future generations unaffected. ✓
Patient pura informed consent deta hai. ✓
Ek serious, painful disease treat karta hai (therapy, enhancement nahi). ✓
Yeh dikhata hai: somatic therapy broadly ethical hai; germline wahan hai jahan controversy rehti hai.
Common mistake "CRISPR unethical hai, bas."Kyun sahi lagta hai: Scary "designer baby" headlines media mein dominate karti hain.
Fix: Ethics type aur purpose par depend karta hai. Somatic therapy (Casgevy) celebrate ki jaati hai. Controversy specifically heritable germline enhancement ke baare mein hai, sabhi editing ke baare mein nahi.
Common mistake "Somatic aur germline editing ek jaisi ethical issues raise karti hain."Kyun sahi lagta hai: Dono same tool use karke DNA edit karte hain.
Fix: Sirf germline edits inherited hoti hain aur descendants ke liye non-consensual hoti hain. Heritability ethical multiplier hai — yeh distinction marks dilata hai.
Common mistake "Kyunki hum disease cure kar sakte hain, enhancement ek logical next step hai."Kyun sahi lagta hai: Dono wellbeing improve karte hain; slippery-slope reasoning.
Fix: Ethicists medical need par line draw karte hain. Enhancement eugenics, inequity, aur consent problems ko invite karta hai jo therapy avoid karti hai.
Common mistake "Off-target effects ek technical problem hai, ethical nahi."Kyun sahi lagta hai: Yeh ek engineering detail lagta hai.
Fix: Germline editing mein ek technical error real future logon ko permanent heritable harm ban jaati hai — woh ethical (non-maleficence) issue hai.
Recall 12 saal ke bacche ko explain karo (click to reveal)Socho tumhare body ki instruction book ek special code mein likhi hai jise DNA kehte hain. Scientists ke paas ab ek tiny "magic scissors" (CRISPR) hai jo book cut karke spelling mistake fix kar sakta hai — jaise koi disease cure karna. Yeh usually achhi baat hai.
Lekin do tarah ke edits hote hain. Ek sirf tumhari book fix karta hai — theek hai, yeh tumhari choice hai. Doosra woh book badalta hai jo tumhare future sabhi bacchon aur unke bacchon mein copy hoti hai, forever. Woh future kids "haan" ya "na" nahi keh sakte kyunki woh abhi born nahi hue! Toh humein bahut careful rehna padega: Agar hum koi aisi galti karein jo undo nahi ho sakti toh? Agar sirf ameer log edits khareed sakein aur "upgraded" ban sakein toh? Yeh worries — fairness, consent, aur ise wapas na le paana — yahi "ethics" ke baare mein hai.
"SAFE-J-D" issues raise karne ke liye:
S afety (off-target) · A utonomy/consent · F uture generations (germline) · E nhancement vs therapy · J ustice/access · D ignity ("playing God").
Aur split yaad raho: "Some Bodies Get Inherited" → S omatic (Body) = inherited nahi; G ermline = I nherited.
Somatic aur germline genome editing mein key difference kya hai? Somatic edits sirf treated individual ko affect karti hain (inherited nahi); germline edits eggs/sperm/embryos mein hoti hain aur sabhi future generations ko pass hoti hain.
Germline editing somatic editing se zyada ethically problematic kyun hai? Yeh heritable aur irreversible hai, aur future generations ko affect karti hai jo consent nahi de sakte.
Genome editing mein therapy aur enhancement mein farq batao. Therapy disease-causing mutation correct karti hai; enhancement non-medical "improvements" add karta hai (e.g. height, intelligence) — enhancement se eugenics aur inequality ka risk hai.
Genome editing analyze karne ke liye chaar ethical pillars kaunse hain? Autonomy/consent, beneficence vs non-maleficence, justice/equity, aur human dignity ("playing God").
Off-target effects kya hain aur yeh ethical (sirf technical nahi) concern kyun hain? Unintended DNA sites par cuts; germline editing mein resulting harm permanent aur heritable ban jaata hai.
He Jiankui (2018) case kya tha aur uski condemnation kyun hui? Usne embryos mein CCR5 gene edit kiya ("CRISPR babies") — koi valid consent nahi, unnecessary (HIV otherwise preventable), koi ethics approval nahi, unknown heritable risks.
Casgevy (sickle-cell CRISPR therapy) ethically acceptable kyun mani jaati hai? Yeh somatic edit hai (inherited nahi), patient informed consent deta hai, aur yeh ek serious disease treat karta hai.
"Genetic divide" concern kya hai? Agar editing expensive hai, sirf wealthy usse access kar sakenge, ek heritable biological class inequality create hogi (justice issue).
Edited embryo mein mosaicism kya hai? Jab embryo ke sirf kuch cells edit hote hain aur baaki nahi, ek unpredictable, mixed genotype deta hai.
Future generations germline edits ke liye consent kyun nahi de sakti? Woh abhi exist nahi karti, isliye woh apne DNA par permanently impose kiye gaye change ke liye agree nahi kar sakti.
CRISPR-Cas9 mechanism — woh tool jisne yeh dilemmas urgent banayeSomatic vs Germline cells — ethics split ka biological basisOff-target effects and Cas fidelity — safety pillarGene therapy — clinical somatic application (e.g. Casgevy)Eugenics history — kyun enhancement se darr lagta haiInformed consent in medicine — autonomy pillarGenetic diversity and the gene pool — population-level risk
Genome Editing CRISPR-Cas9
Beneficence vs off-target harm
Human dignity / playing God
Heritable and irreversible
Enhancement / designer babies
Eugenics and discrimination
